NPI: 1902360019 · COLUMBIA, MO 65201 · Clinical Medical Laboratory · NPI assigned 01/23/2019
Authorized official BOWLES, CHARLES controls 20+ related entities in our dataset. Read more
| Authorized Official | BOWLES, CHARLES (VICE PRESIDENT) |
| Parent Organization | QUEST DIAGNOSTICS INCORPORATED |
| NPI Enumeration Date | 01/23/2019 |
Other providers sharing the same authorized official: BOWLES, CHARLES
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 68,857 | $697K |
| 2019 | 3,571 | $63K |
| 2020 | 702 | $11K |
| 2021 | 545 | $13K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 1,638 | 1,304 | $198K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,232 | 1,711 | $96K |
| 80061 | Lipid panel | 3,842 | 3,621 | $40K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 560 | 481 | $40K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6,207 | 4,497 | $37K |
| 80053 | Comprehensive metabolic panel | 4,801 | 3,963 | $37K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3,858 | 3,620 | $30K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 995 | 854 | $22K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,685 | 1,544 | $20K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 796 | 721 | $20K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 797 | 724 | $20K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 177 | 170 | $19K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 821 | 755 | $19K |
| 80164 | 1,173 | 1,038 | $14K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 726 | 680 | $13K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,797 | 1,369 | $12K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,593 | 1,421 | $9K |
| 84439 | 1,210 | 1,125 | $8K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 305 | 287 | $8K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 386 | 359 | $8K |
| 82607 | 630 | 579 | $8K | |
| 86780 | 664 | 614 | $6K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 233 | 214 | $6K |
| 83880 | 195 | 168 | $5K | |
| 87186 | 660 | 573 | $5K | |
| 87077 | 670 | 587 | $5K | |
| 87340 | 529 | 496 | $4K | |
| 84481 | 333 | 310 | $4K | |
| 86762 | 341 | 309 | $4K | |
| 80177 | 340 | 299 | $4K | |
| 86803 | 334 | 320 | $4K | |
| 82746 | 314 | 289 | $4K | |
| 80178 | 603 | 545 | $3K | |
| 80076 | 600 | 537 | $3K | |
| 82140 | 233 | 202 | $3K | |
| 87522 | Neg quan hep c or qual rna | 82 | 67 | $3K |
| 85610 | 1,050 | 523 | $3K | |
| 84153 | 158 | 148 | $3K | |
| 82728 | 230 | 214 | $2K | |
| 86850 | 327 | 299 | $2K | |
| 80156 | 164 | 153 | $2K | |
| 84436 | 371 | 351 | $2K | |
| 82947 | 590 | 554 | $2K | |
| 84146 | 132 | 126 | $2K | |
| 81001 | 843 | 711 | $2K | |
| 87070 | 332 | 285 | $2K | |
| 83540 | 298 | 275 | $2K | |
| 83735 | 326 | 243 | $2K | |
| 83550 | 223 | 207 | $2K | |
| 82570 | 381 | 349 | $2K | |
| 82043 | 343 | 313 | $1K | |
| 86706 | 152 | 143 | $1K | |
| 81003 | 670 | 608 | $1K | |
| 87400 | 93 | 76 | $1K | |
| 80074 | 28 | 24 | $1K | |
| 86704 | 91 | 87 | $934.10 | |
| 86140 | 195 | 154 | $833.66 | |
| 86900 | 328 | 302 | $778.31 | |
| 86901 | 322 | 300 | $766.78 | |
| 86696 | 49 | 48 | $742.68 | |
| 80175 | 57 | 55 | $666.08 | |
| 87075 | 94 | 75 | $604.26 | |
| 85652 | 248 | 208 | $515.00 | |
| 85027 | 85 | 78 | $399.80 | |
| 84702 | 34 | 27 | $373.43 | |
| 87147 | 79 | 67 | $351.55 | |
| 80185 | 29 | 24 | $297.46 | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 1,145 | 750 | $295.80 |
| 84134 | 25 | 24 | $288.80 | |
| 84479 | 60 | 55 | $269.63 | |
| 84144 | 20 | 12 | $247.20 | |
| 84550 | 63 | 55 | $217.35 | |
| 80201 | 15 | 13 | $164.78 | |
| 80069 | 28 | 26 | $164.40 | |
| 86038 | 15 | 15 | $161.02 | |
| 82274 | 12 | 12 | $150.10 | |
| 86695 | 13 | 13 | $115.18 | |
| 87081 | 41 | 33 | $101.64 | |
| 36415 | Collection of venous blood by venipuncture | 11,093 | 7,845 | $75.12 |
| 82550 | 13 | 12 | $68.73 | |
| 83690 | 13 | 12 | $66.00 | |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | 936 | 529 | $60.35 |
| 83655 | 13 | 12 | $59.80 | |
| 82565 | 12 | 12 | $54.66 | |
| 83615 | 19 | 12 | $35.76 | |
| 99082 | 7,382 | 4,808 | $0.00 | |
| 80050 | General health panel | 2,046 | 1,938 | $0.00 |
| 36416 | 29 | 25 | $0.00 |